Suppressive effects of wild bitter gourd (Momordica charantia Linn. var. abbreviata ser.) fruit extracts on inflammatory responses in RAW 264.7 macrophages

Journal of Ethnopharmacology

Volumn 122, Issue 2, 2009, Pages 227-233

  Lii, Chong Kuei ^a   Chen, Haw Wen ^a   Yun, Wen Tzu ^b   Liu, Kai Li ^b  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

^b CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Inducible nitric oxide synthase; Momordica charantia Linn. var. abbreviata ser.; NF B; Nitric oxide; Wild bitter gourd

Indexed keywords

CYCLOOXYGENASE 2; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; MOMORDICA CHARANTIA EXTRACT; NITRIC OXIDE; PROSTAGLANDIN E2;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; DRUG INHIBITION; ENZYME ACTIVATION; GEL MOBILITY SHIFT ASSAY; INFLAMMATION; MACROPHAGE; MOMORDICA CHARANTIA; MOUSE; NONHUMAN; PROTEIN EXPRESSION;

ANIMALS; ANTI-INFLAMMATORY AGENTS; CELLS, CULTURED; CYCLOOXYGENASE 2; DINOPROSTONE; FRUIT; HUMANS; INTERLEUKIN-1BETA; LIPOPOLYSACCHARIDES; MACROPHAGES; MICE; MOMORDICA CHARANTIA; NF-KAPPA B; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; PHENOLS; PLANT EXTRACTS;

ABBREVIATA; MOMORDICA CHARANTIA;

EID: 60849121701     PISSN: 03788741     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jep.2009.01.028     Document Type: Article

References (43)

1. Anderson Jr. E.N. 'Heating" and 'cooling' foods in Hong Kong and Taiwan. Social Sciences Information 25 (1980) 331-337
2. Appleby S.B., Ristimaki A., Neilson K., Narko K., and Hla T. Structure of the human cyclo-oxygenase-2 gene. The Biochemical Journal 302 (1994) 723-727
3. Baeuerle P.A., and Henkel T. Function and activation of NF-kappa B in the immune system. Annual Review of Immunology 12 (1994) 141-179
4. Baldwin A.S. The NF-kappa B and I kappa B proteins: new discoveries and insights. Annual Review of Immunology 14 (1996) 649-683
5. Basch E., Gabardi S., and Ulbricht C. Bitter melon (Momordica charantia): a review of efficacy and safety. American Journal of Health-System Pharmacy 60 (2003) 356-359
6. Becker J., Delayre-Orthez C., Frossard N., and Pons F. Regulation of inflammation by PPARs: a future approach to treat lung inflammatory diseases?. Fundamental and Clinical Pharmacology 20 (2006) 429-447
7. Blumenthal M. New World plants. New World drugs. Allergy Proceedings 13 (1992) 345-352
8. Bruck W. The pathology of multiple sclerosis is the result of focal inflammatory demyelination with axonal damage. Journal of Neurology 252 (2005) 3-9
9. Chao C.Y., and Huang C.J. Bitter gourd (Momordica charantia) extract activates peroxisome proliferator-activated receptors and upregulates the expression of the acyl CoA oxidase gene in H4IIEC3 hepatoma cells. Journal of Biomedical Science 10 (2003) 782-791
10. Chen F., Castranova V., Shi X., and Demers L.M. New insights into the role of nuclear factor-kappaB, a ubiquitous transcription factor in the initiation of diseases. Clinical Chemistry 45 (1999) 7-17
11. Cheng W.L., Lii C.K., Chen H.W., Lin T.H., and Liu K.L. Contribution of conjugated linoleic acid to the suppression of inflammatory responses through the regulation of the NF-κB pathway. Journal of Agricultural and Food Chemistry 52 (2004) 71-78
12. Chuang C.Y., Hsu C., Chao C.Y., Wein Y.S., Kuo Y.H., and Huang C.J. Fractionation and identification of 9c, 11t, 13t-conjugated linolenic acid as an activator of PPAR alpha in bitter gourd (Momordica charantia L.). Journal of Biomedical Science 13 (2006) 763-772
13. de Boer O.J., van der Wal A.C., and Becker A.E. Atherosclerosis, inflammation, and infection. The Journal of Pathology 190 (2000) 237-243
14. Denizot F., and Lang R. Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability. Journal of Immunological Methods 89 (1986) 271-277
15. Green L.C., Wagner D.A., Glogowski J., Skipper P.L., Wishnok J.S., and Tannenbaum S.R. Analysis of nitrate, nitrite, and [15N]-nitrate in biological fluids. Analytical Biochemistry 126 (1982) 131-138
16. Grover J.K., and Yadav S.P. Pharmacological actions and potential uses of Momordica charantia: a review. Journal of Ethnopharmacology 93 (2004) 123-132
17. Harinantenaina L., Tanaka M., Takaoka S., Oda M., Mogami O., Uchida M., and Asakawa Y. Momordica charantia constituents and antidiabetic screening of the isolated major compounds. Chemical and Pharmaceutical Bulletin 54 (2006) 1017-1021
18. Henkel T., Machleidt T., Alkalay I., Kronke M., Ben-Neriah Y., and Baeuerle P.A. Rapid proteolysis of I kappa B-alpha is necessary for activation of transcription factor NF-kappa B. Nature 365 (1993) 182-185
19. Hinz B., Kraus V., Pahl A., and Brune K. Salicylate metabolites inhibit cyclooxygenase-2-dependent prostaglandin E(2) synthesis in murine macrophages. Biochemical and Biophysical Research Communications 274 (2000) 197-202
20. Holmes Jr. T.J., Vennerstrom J.L., and John V. Inhibition of cyclooxygenase mediated by electrochemical oxidation of gentisic acid. The Journal of Biological Chemistry 260 (1985) 14092-14095
21. Holtzman M.J., Morton J.D., Shornick L.P., Tyner J.W., O'Sullivan M.P., Antao A., Lo M., Castro M., and Walter M.J. Immunity, inflammation, and remodeling in the airway epithelial barrier: epithelial-viral-allergic paradigm. Physiological Reviews 82 (2002) 19-46
22. Horax R., Hettiarachchy N., and Islam S. Total phenolic contents and phenolic acid constituents in 4 varieties of bitter melons (Momordica charantia) and antioxidant activities of their extracts. Journal of Food Science 70 (2005) C275
23. Huang C.J., and Wu M.C. Differential effects of foods traditionally regarded as 'heating' and 'cooling' on prostaglandin E(2) production by a macrophage cell line. Journal of Biomedical Science 9 (2002) 596-606
24. Husain J., Tickle I.J., and Wood S.P. Crystal structure of momordin, a type I ribosome inactivating protein from the seeds of Momordica charantia. FEBS Letters 342 (1994) 154-158
25. Ike K., Uchida Y., Nakamura T., and Imai S. Induction of interferon-gamma (IFN-gamma) and T helper 1 (Th1) immune response by bitter gourd extract. The Journal of Veterinary Medical Science 67 (2005) 521-524
26. Kleinert H., Schwarz P.M., and Förstermann U. Regulation of the expression of inducible nitric oxide synthase. Biological Chemistry 384 (2003) 1343-1364
27. Kobori M., Amemiya J., Sakai M., Shiraki M., Sugishita H., Sakaue N., Hoshi Y., and Yukizaki C. Bitter gourd induces apoptosis in HL60 human leukemia cells and suppresses the Production of Inflammatory cytokine in RAW 264.7 macrophage like cells. Nippon Shokuhin Kagaku Kogaku Kaishi 53 (2006) 408-415
28. Kohno H., Yasui Y., Suzuki R., Hosokawa M., Miyashita K., and Tanaka T. Dietary seed oil rich in conjugated linolenic acid from bitter melon inhibits azoxymethane-induced rat colon carcinogenesis through elevation of colonic PPAR gamma expression and alteration of lipid composition. International Journal of Cancer 110 (2004) 896-901
29. Krawinkel M.B., and Keding G.B. Bitter gourd (Momordica charantia): a dietary approach to hyperglycemia. Nutrition Reviews 64 (2006) 331-337
30. Kumar S., Ziereis K., Wiegrebe W., and Muller K. Medicinal plants from Nepal: evaluation as inhibitors of leukotriene biosynthesis. Journal of Ethnopharmacology 70 (2000) 191-195
31. Manabe M., Takenaka R., Nakasa T., and Okinaka O. Induction of anti-inflammatory responses by dietary Momordica charantia L. (bitter gourd). Bioscience, Biotechnology, and Biochemistry 67 (2003) 2512-2517
32. Murakami T., Emoto A., Matsuda H., and Yoshikawa M. Medicinal foodstuffs. XXI. Structures of new cucurbitane-type triterpene glycosides, goyaglycosides-a, -b, -c, -d, -e, -f, -g, and -h, and new oleanane-type triterpene saponins, goyasaponins I, II, and III, from the fresh fruit of Japanese Momordica charantia L. Chemical and Pharmaceutical Bulletin 49 (2001) 54-63
33. Nurmi K., Ossipov V., Haukioja E., and Pihlaja K. Variation of total phenolic content and individual low-molecular-weight phenolics in foliage of mountain birch trees (Betula pubescens ssp. tortuosa). Journal of Chemical Ecology 22 (1996) 2023-2040
34. Paterson T.J., Baxter G., Lawrence J., and Duthie G. Is there a role for dietary salicylates in health?. The Proceedings of the Nutrition Society 65 (2006) 93-96
35. Rychly J., and Nebe B. Therapeutic strategies in autoimmune diseases by interfering with leukocyte endothelium interaction. Current Pharmaceutical Design 12 (2006) 3799-3806
36. Smith W.L., DeWitt D.L., and Garavito R.M. Cyclooxygenases: structural, cellular, and molecular biology. Annual Review of Biochemistry 69 (2000) 145-182
37. Stylianou E., and Saklatvala J. Interleukin-1. The International Journal of Biochemistry and Cell Biology 30 (1998) 1075-1079
38. Suzuki R., Arato S., Noguchi R., Miyashita K., and Tachikawa O. Occurrence of conjugated linolenic acid in fresh and seed of bitter gourd. Journal of Oleo Science 50 (2001) 71-76
39. Tak P.P., and Firestein G.S. NF-kappa B: a key role in inflammatory diseases. The Journal of Clinical Investigation 107 (2001) 7-11
40. Xie Q.W., Kashiwabara Y., and Nathan C. Role of transcription factor NF-kappa B/Rel in induction of nitric oxide synthase. The Biochemical Journal 269 (1994) 4705-4708
41. Xie H., Huang S., Deng H., Wu Z., and Ji A. Study on chemical components of Momordica charantia. Zhong Yao Cai 21 (1998) 458-459
42. Yasui Y., Hosokawa M., Sahara T., Suzuki R., Ohgiya S., Kohno H., Tanaka T., and Miyashita K. Bitter gourd seed fatty acid rich in 9c, 11t, 13t-conjugated linolenic acid induces apoptosis and up-regulates the GADD45, p53 and PPAR gamma in human colon cancer Caco-2 cells. Prostaglandins, Leukotrienes, and Essential Fatty Acids 73 (2005) 113-119
43. Yoon J.H., and Baek S.J. Molecular targets of dietary polyphenols with anti-inflammatory properties. Yonsei Medical Journal 46 (2005) 585-596